Источники / Питание для здоровья - от традиций к современности

08.12.2024
  1. Tiwari S, Kavitake D, Devi PB, Halady Shetty P. Bacterial exopolysaccharides for improvement of technological, functional and rheological properties of yoghurt. Int J Biol Macromol. 2021 Jul 31;183:1585-1595. doi: 10.1016/j.ijbiomac.2021.05.140. 
  2. Castro-Bravo N, Wells JM, Margolles A, Ruas-Madiedo P. Interactions of Surface Exopolysaccharides From Bifidobacterium and Lactobacillus Within the Intestinal Environment. Front Microbiol. 2018 Oct 11;9:2426. doi: 10.3389/fmicb.2018.02426.
  3. ТР ТС 033/2013 Технический регламент Таможенного союза "О безопасности молока и молочной продукции"
  4. Hasler CM, Brown AC; Academy of Nutrition and Dietetics. "Position of the Academy of Nutrition and Dietetics: functional foods." J Am Diet Assoc. 2009 Apr;109(4):735-46. U.S. Food and Drug Administration. "Claims That Can Be Made for Conventional Foods and Dietary Supplements." Accessed August 16, 2011. Интернет-сайт http://www.fda.gov/Food/LabelingNutrition/LabelClaims/ucm111447.htm.
  5. Toh M, Liu SQ. Impact of coculturing Bifidobacterium animalis subsp. lactis HN019 with yeasts on microbial viability and metabolite formation. J Appl Microbiol. 2017 Oct;123(4):956-968. https://doi.org/10.1111/jam.13571
  6. Marteau P., Le Nevé B., Quinquis L., Pichon C., Whorwell P. A post-hoc pooled analysis of two previously published clinical studies (randomized, double-blind, controlled) with a fermented milk containing probiotic Bifidobacterium lactis CNCM I-2494 in healthy women reporting minor digestive symptoms after 4 weeks of consumption.  Nutrients. 2019 Jan; 11(1): 92. (Open access) Duez H, Pelletier C, Cools S, Aissi E, Cayuela C, Gavini F, Bouquelet S, Neut C, Mengaud J. A colony immunoblotting method for quantitative detection of a Bifidobacterium animalis probiotic strain in human faeces. Journal of Applied Microbiology, 2000; 88:1019-27. Pochart P, Marteau P, Bouhnik Y, Goderel I, Bourlioux P, Rambaud J.C. Survival of Bifidobacteria ingested via fermented milk during their passage through the human small intestine: an in vivo study using intestinal perfusion. American Journal of Clinical Nutrition, 1992; 55:78-80.
  7. Rochet V, Rigottier-Gois L, Ledaire A, Andrieux C, Sutren M, Rabot S, Mogenet A, Bresson J.L., Cools S, Picard C, Goupil-Feuillerat N, Doré J. Survival of Bifidobacterium animalis DN-173 010 in the fecal microbiota after administration in lyophilised form or in fermented product - A randomized study in healthy adults. Journal of Molecular Microbiology and Biotechnology, 2008; 14: 128-136   Veiga P., Pons N., Agrawal A., Oozeer R., Guyonnet D., Brazeilles R., Faurie J.M., van Hylckama Vlieg J.E., Houghton L.A., Whorwell P.J., Ehrlich S.D., Kennedy S.P. Changes of the human gut microbiome induced by  a fermented milk product. Scientific Reports. 2014 Sep 11;4:6328   McNulty N.P, Yatsunenko T, Hsiao A, Faith J.J, Muegge B.D, Goodman A.L, Henrissat B, Oozeer R, Cools-Portier S, Gobert G, Chervaux C, Knights D, Lozupone C.A, Knight R, Duncan A.E, Bain J.R, Muehlbauer M.J, Newgard C.B, Heath A.C, Gordon J.I. The impact of a consortium of fermented milk strains on the gut microbiome of gnotobiotic mice and monozygotic twins. Science Translation Medicine, 2011; 3(106):106ra106.
  8. Marteau P, Cuillerier E, Méance S, Gerhardt MF, Myara A, Bouvier M, Bouley C, Tondu F, Bommelaer G, Grimaud JC. Bifidobacterium animalis strain DN-173 010 shortens the colonic transit time in healthy women: a double-blind, randomized, controlled study. Alimentary Pharmacol & Therap, 2002;16:587-93. Agrawal A, Houghton L.A, Morris J, Reilly B, Guyonnet D, Goupil-Feuillerat N, Schlumberger A, Jakob S, Whorwell P.J. Clinical trial: the effects of a fermented milk product containing Bifidobacterium  lactis DN-173 010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation. Alimentary Pharmacology and Therapeutics, 2009; 29(1): 104-114.
  9. Marteau P, Guyonnet D, Lafaye de Micheaux P, Gelu S. A randomized, double-blind, controlled study and pooled analysis of two identical trials of fermented milk containing probiotic Bifidobacterium lactis CNCM I-2494 in healthy women reporting minor digestive symptoms. Neurogastroenterol Motil. 2013 Apr;25(4):331-e252. Guyonnet D, Schlumberger A, Mhamdi L, Jakob S, Chassany O. Fermented milk containing Bifidobacterium lactis DN-173 010 improves gastrointestinal well-being and digestive symptoms in women reporting minor digestive symptoms: a randomized, double-blind, parallel, controlled study. British Journal of Nutrition, 2009; 102(11):1654-62.   Tillisch K, Labus J, Kilpatrick L, Jiang Z, Stains J, Ebrat B, Guyonnet D, Legrain-Raspaud S, Trotin B, Naliboff B, Mayer EA. Consumption of Fermented Milk Product with Probiotic Modulates Brain Activity. Gastroenterology, 2013 Jun; 144(7):1394-1401
  10. Waitzberg D.L., Quilici F.A., Michzputen S., Friche Passos M.D. The effect of probiotic fermented milk that includes Bifidobacterium lactis CNCM I-2494 on the reduction of gastrointestinal discomfort and symptoms in adults: a narrative review. Nutricion Hospitalaria. 2015 Aug 1;32(n02):501-509 Eales J., Gibson P.R., Whorwell P.J., Kellow J., Yellowlees A., Perry R., Edwards M., King S., Wood H., Glanville J. Systematic review and meta-analysis: the effects of fermented milk with Bifidobacterium lactis CNCM I-2494 and lactic acid bacteria on gastrointestinal discomfort in the general adult population. Therap Adv Gastroenterol. 2016. First  published on October 9, 2016.
  11. Agrawal A, Houghton L.A, Morris J, Reilly B, Guyonnet D, Goupil-Feuillerat N, Schlumberger A, Jakob S, Whorwell P.J. Clinical trial: the effects of a fermented milk product containing Bifidobacterium  lactis DN-173 010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation. Alimentary Pharmacology and Therapeutics, 2009; 29(1): 104-114.
  12. Guyonnet D, Chassany O, Ducrotte P, Picard C, Mouret M, Mercier C.H, Matuchansky C. Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double-blind, controlled trial. Alimentary Pharmacology and Therapeutics, 2007; 26 (3): 475-486.
  13.  Oyarzun I, Le Nevé B, Yañez F, Xie Z, Pichaud M, Serrano-Gómez G, Roca J, Veiga P, Azpiroz F, Tap J, Manichanh C. Human gut metatranscriptome changes induced by a fermented milk product are associated with improved tolerance to a flatulogenic diet. Comput Struct Biotechnol J. 2022 Apr 5;20:1632-1641. doi: 10.1016/j.csbj.2022.04.001.